Skip to main content
Toggle navigation
Login
Search
Home
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
X
Xiao, Ying
University of Pennsylvania
Paper 67 - NRG-DT001 PHASE IB TRIAL OF NEOADJUVANT NAVTEMADLIN AND RADIOTHERAPY IN TP53 WILD-TYPE SOFT TISSUE SARCOMA: PRELIMINARY EFFICACY ANALYSIS
Location: Royal Palm Ballroom
Ying Xiao
Favorite
Xie, Jing
Duke University
Paper 20 - ESM1 FACILITATES UPS LUNG METASTASIS BY INFLAMMATORY AND REGENERATIVE REGULATORS IN ENDOTHELIAL CELLS
Location: Royal Palm Ballroom
Jing Xie
Favorite
Xie, Lu
Musculoskeletal Tumor Centre, Peking University People's Hospital
Paper 07 - ARTEMIS-002: A PHASE 2 STUDY OF HS-20093 IN PATIENTS WITH RELAPSED OR REFRACTORY SARCOMAS
Location: Royal Palm Ballroom
Lu Xie
Favorite
Xie, Lu
Peking University People's Hospital
Paper 10 - TQB2928, A NOVEL ANTI-CD47 MONOCLONAL ANTIBODY, IN COMBINATION WITH ANLOTINIB FOR THE TREATMENT OF RECURRENT/METASTATIC OSTEOSARCOMA: A PHASE 1B STUDY
Location: Royal Palm Ballroom
Lu Xie
Favorite
Xue, Wei
COG Data Center
Paper 58 - CIRCULATING TUMOR DNA IN PATIENTS WITH INTERMEDIATE RISK RHABDOMYOSARCOMA ON ARST1431: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Location: Royal Palm Ballroom
Wei Xue
Favorite
Xu, Jie
Musculoskeletal Tumor Centre, Peking University People's Hospital
Paper 07 - ARTEMIS-002: A PHASE 2 STUDY OF HS-20093 IN PATIENTS WITH RELAPSED OR REFRACTORY SARCOMAS
Location: Royal Palm Ballroom
Jie Xu
Favorite
Paper 10 - TQB2928, A NOVEL ANTI-CD47 MONOCLONAL ANTIBODY, IN COMBINATION WITH ANLOTINIB FOR THE TREATMENT OF RECURRENT/METASTATIC OSTEOSARCOMA: A PHASE 1B STUDY
Location: Royal Palm Ballroom
Jie Xu
Favorite
Xu, Rui-Hua
Sun Yat-sen University Cancer Center
Paper 01 - LAROTRECTINIB (LARO) SAFETY AND EFFICACY IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS AND PROLONGED RESPONSE
Location: Royal Palm Ballroom
Rui-Hua Xu
Favorite